 | Up a level |
Number of items: 2.
Hoffmann, C., Welz, T., Sabranski, M., Kolb, M., Wolf, E., Stellbrink, H-J and Wyen, C. (2017). Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients. HIV Med., 18 (1). S. 56 - 64. HOBOKEN: WILEY-BLACKWELL. ISSN 1468-1293
Hoffmann, C., Welz, T., Sabranski, M., Kolb, M., Wolf, E., Stellbrink, H-J and Wyen, C. (2018). Reply to Letter Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti etal. HIV Med., 19 (5). S. E60 - 2. HOBOKEN: WILEY. ISSN 1468-1293